BGNE Nov 2024 210.000 call
| Previous Close | 9.50 |
| Open | 9.50 |
| Bid | 8.00 |
| Ask | 12.00 |
| Strike | 210.00 |
| Expire Date | 2024-11-15 |
| Day's Range | 9.50 - 9.50 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 1 |
CNW GroupBiotech Leader, BeiGene, Inaugurates Office in Toronto, Canada
BeiGene Canada, the country affiliate of global oncology company BeiGene, specializing in the discovery and development of novel, affordable, and accessible oncology medications, has opened its first office in Canada. Situated in downtown Toronto, the new office space will be the Canadian headquarters where the company will work to extend the boundaries of 'the possible,' fulfilling BeiGene's promise of delivering best-in-class, innovative treatments to the Canadian cancer community.
Business WireBeiGene Demonstrates Global Progress in 2023 Responsible Business & Sustainability Report
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass., April 26, 2024--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, released its 2023 Responsible Business & Sustainability Report highlighting the Company’s strategy, the progress it has made towards existing goals, and how it intends to achieve its bold new targets.
Insider Monkey20 Countries with the Highest Rates of Stomach Cancer in the World
In this article, we will be taking a look at the 20 countries with the highest rates of stomach cancer in the world. If you do not want to learn about the global cancer trends, head straight to the 5 Countries with the Highest Rates of Stomach Cancer in the World. Overview of the Global […]
